Conventional versus rubber band traction-assisted endoscopic submucosal dissection for rectal neuroendocrine tumors: a single-center retrospective study (with video)-Reference-Cited by-同舟云学术

Conventional versus rubber band traction-assisted endoscopic submucosal dissection for rectal neuroendocrine tumors: a single-center retrospective study (with video)

Published:2024-09-13 Issue: Volume: Page:
ISSN:0930-2794
Container-title:Surgical Endoscopy
language:en
Short-container-title:Surg Endosc

Author:

Peng Jinbang,Lin Jiajia,Fang Lina,Zhou Jingjing,Song Yaqi,Yang Chaoyu,Zhang Yu,Gu Binbin,Ji Ziwei,Lu Yandi,Mao Xinli,Yan Lingling^ORCID

Funder

Medical Science and Technology Project of Zhejiang Province

Science and Technology Program of Zhejiang Province

Program of Taizhou Science and Technology Grant

Scientific Research Fund Program of Enze Medical Center

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00464-024-11244-5.pdf

Reference28 articles.

1. Chen J, Ye J, Zheng X, Chen J (2024) Endoscopic treatments for rectal neuroendocrine tumors: a systematic review and network meta-analysis. J Gastrointest Surg 28:301–308

2. Maione F, Chini A, Milone M, Gennarelli N, Manigrasso M, Maione R, Cassese G, Pagano G, Tropeano F, Luglio G, De Palma G (2021) Diagnosis and management of rectal neuroendocrine tumors (NETs). Diagnostics 11:771

3. Basuroy R, Haji A, Ramage JK, Quaglia A, Srirajaskanthan R (2016) Review article: the investigation and management of rectal neuroendocrine tumours. Aliment Pharmacol Ther 44:332–345

4. Ramage JK, De Herder WW, Delle Fave G, Ferolla P, Ferone D, Ito T, Ruszniewski P, Sundin A, Weber W, Zheng-Pei Z, Taal B, Pascher A, Vienna Consensus Conference p (2016) ENETS Consensus Guidelines update for colorectal neuroendocrine neoplasms. Neuroendocrinology 103:139–143

5. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB (2008) One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26:3063–3072